129 related articles for article (PubMed ID: 406999)
1. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
Felt V; Nedvídková J; Krejcík L; Hainer V
Cas Lek Cesk; 1977 May; 116(19):591-4. PubMed ID: 406999
[No Abstract] [Full Text] [Related]
2. [Dopaminergic blockage using pimozide and dopaminergic stimulation using bromocryptin. Effect on secretion of somatotropin].
Hainer V; Krejcík L; Urbánek J; Tvaroh F
Cas Lek Cesk; 1977 Jan; 116(2):11-6. PubMed ID: 576415
[No Abstract] [Full Text] [Related]
3. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
Delitala G; Masala A; Alagna S; Devilla L; Lotti G
J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
[TBL] [Abstract][Full Text] [Related]
4. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism.
Felt V; Nedvdková J
Horm Metab Res; 1977 Jul; 9(4):274-7. PubMed ID: 408253
[TBL] [Abstract][Full Text] [Related]
5. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
6. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic evaluation of prolactin secretion in acromegaly (author's transl)].
Chacra AR; Zampieri M; Lengyel AM; Vieira JG
Rev Bras Pesqui Med Biol; 1980 Apr; 13(1-3):57-64. PubMed ID: 6774385
[TBL] [Abstract][Full Text] [Related]
8. Effects of pirenzepine, bromocriptine and their association on basal and GHRH- and TRH-induced GH secretion in acromegaly.
Fiszlejder L; Penacini O; Ratz S; Storani M; Oneto A; Guitelman A
Horm Res; 1991; 36(1-2):47-51. PubMed ID: 1814801
[TBL] [Abstract][Full Text] [Related]
9. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
[TBL] [Abstract][Full Text] [Related]
10. Effect of ergot alkaloids on growth hormone and prolactin secretion in humans.
Silvestrini F; Liuzzi A; Chiodini PG
Pharmacology; 1978; 16 Suppl 1():78-87. PubMed ID: 643905
[TBL] [Abstract][Full Text] [Related]
11. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
[TBL] [Abstract][Full Text] [Related]
12. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly.
Hanew K; Sasaki A; Mouri T; Yoshinaga K
Acta Endocrinol (Copenh); 1980 Nov; 95(3):298-307. PubMed ID: 6776756
[No Abstract] [Full Text] [Related]
13. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
14. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
[No Abstract] [Full Text] [Related]
15. [Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
Dolecek R
Cas Lek Cesk; 1976 Aug; 115(33-34):1056-7. PubMed ID: 989744
[No Abstract] [Full Text] [Related]
16. Bromoergocriptine and growth hormone (GH) dynamics in health and hypersomatotropism.
Sachdev Y
J Assoc Physicians India; 1983 Apr; 31(4):195-9. PubMed ID: 6417104
[No Abstract] [Full Text] [Related]
17. [Acromegaly. Recent physiopathological and therapeutic acquisitions].
Silvestrini F
Minerva Med; 1979 Mar; 70(15):1065-8. PubMed ID: 108635
[No Abstract] [Full Text] [Related]
18. [Follow up of 30 cases of prolactin -- or somatotropin -- secreting adenomas after trans-spenoidal surgery (author's transl)(proceedings)].
Jaquet P; Grisoli F; Guibout M; Lissitzky JC
Ann Endocrinol (Paris); 1976; 37(4):283-4. PubMed ID: 828840
[No Abstract] [Full Text] [Related]
19. Effect of thyroid status on the prolactin-releasing action of vasoactive intestinal peptide in humans: comparison with the action of thyrotropin-releasing hormone.
Watanobe H; Sasaki S
Neuroendocrinology; 1995 Feb; 61(2):207-12. PubMed ID: 7753340
[TBL] [Abstract][Full Text] [Related]
20. Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).
Agnati LF; Benfenati F; Frank G; Capelli M; Bernardi P; Calza L
Med Biol; 1981 Feb; 59(1):58-63. PubMed ID: 7266088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
